...
首页> 外文期刊>European journal of pharmaceutical sciences >Combining amorphous solid dispersions for improved kinetic solubility of posaconazole simultaneously released from soluble PVP/VA64 and an insoluble ammonio methacrylate copolymer
【24h】

Combining amorphous solid dispersions for improved kinetic solubility of posaconazole simultaneously released from soluble PVP/VA64 and an insoluble ammonio methacrylate copolymer

机译:组合无定形固体分散体,用于改善双酰基唑同时从可溶性PVP / VA64释放的释放的动力学溶解度和不溶性氨基甲酸甲基丙烯酸酯共聚物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to evaluate the potential of combining multiple ASDs based on water soluble and insoluble polymers to reach and maintain poorly soluble posaconazole (PCZ) supersaturation over time. ASDs of PCZ were obtained with PVP/VA64 or an ammonio methacrylate copolymer by solvent evaporation method with a fixed 20% (wt/wt%) drug loading ratio and physical mixtures of these ASDs were prepared at various proportions. ASDs were characterized by Fourier transform infrared spectroscopy (FT-IR) and powder X-ray diffraction (PXRD) and compared to their respective physical mixture with crystalline PCZ. Crystalline PCZ equilibrium solubility was determined at pH 1.2-2 range. Dissolution profiles were constructed under non-sink condition with an adapted dissolution system. PXRD analysis demonstrated that both ASDs were at the amorphous state and FT-IR spectroscopy revealed that the analytical signal of PCZ was also absent in both ASDs. Equilibrium solubility of crystalline PCZ varied between 26.36 +/- 0.32 (pH 2) to 609.33 +/- 3.68 (pH 1.2) mu g/mL. All ASDs reached higher concentrations than the equilibrium solubility of crystalline PCZ during dissolution. PVP/VA64 ASDs showed dominance over PCZ dissolution and recrystallization rates whereas Eudragit RS PO ASD alone did not cause PCZ recrystallization whatsoever. The combination containing 20 mg PVP/VA64 + 80 mg Eudragit RS PO as PCZ carriers obtained the highest AUC, suggesting that even after the PVP/VA64 part was completely dissolved, reaching a concentration above crystalline PC Cs, the insoluble polymer could still release PCZ slowly and maintain supersaturation over time. The research demonstrated a potential of combining multiple ASDs to achieve distinct dissolution profiles while increasing the kinetic solubility of poorly soluble drugs.
机译:本研究的目的是评估基于水溶性和不溶性聚合物组合多个ASDS的电位,以随着时间的推移而达到和保持差异的松酰基唑(PCZ)过饱和度。通过PVP / Va64或通过溶剂蒸发法得到PCZ的ASDS,通过固定的20%(wt / wt%)药物负载比和这些ASD的物理混合物以各种比例进行溶剂蒸发方法。 ASDS的特征在于傅里叶变换红外光谱(FT-IR)和粉末X射线衍射(PXRD),并与其各自的物理混合物与结晶PCZ相比。在pH 1.2-2范围内测定结晶PCZ平衡溶解度。在具有适应性溶解系统的非沉淀条件下构建溶解曲线。 PXRD分析表明,ASDS在非晶态和FT-IR光谱中显示,在ASD中也不存在PCZ的分析信号。结晶PCZ的平衡溶解度在26.36 +/- 0.32(pH 2)之间变化至609.33 +/- 3.68(pH 1.2)mu g / ml。所有ASD均达到较高浓度,而不是溶解期间结晶PCZ的平衡溶解度。 PVP / VA64 ASDS在PCZ溶出度和重结符中显示出优势,而eudragit rs Po Asd独自没有引起PCZ重结晶。含有20mg PVP / VA64 + 80mg eudragit的组合作为PCZ载体获得的最高AUC,表明即使在PVP / VA64部分完全溶解后,即使在结晶PC CS的浓度上达到浓度,也可以仍然可以释放PCZ慢慢地随着时间的推移保持过饱和度。该研究证明了组合多个ASDS以实现不同的溶解曲线,同时增加可溶性药物差的动力学溶解度。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号